NanoSyrinx appoints Anthony Johnson as Non-Executive Director

Appointment of Big Pharma executive strengthens leadership team to drive ambitious growth strategy.

Pharmalittle: We’re reading about Amylyx pulling its ALS drug, GLP-1 drugs for Parkinson’s, and more

Top of the morning to you, and a fine one it is. After two days of downpours and strong winds, the Pharmalot campus is now

April 4, 2024

Seagen’s former commercial chief joins the board at healthcare agency minds + assembly

Longtime oncology commercial leader Chip Romp is making a creative leap and joining the board of directors at design-focused healthcare agency minds + assembly. Romp

March 23, 2024

Algernon Pharmaceuticals Reports Results of Study Showing 93% Cough Suppression with Ifenprodil | Psychedelic Invest

VANCOUVER, British Columbia, July 16, 2024 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical

July 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.